Searched over 200M research papers
10 papers analyzed
These studies suggest insulin is produced through various methods including regulation by glucose and proteases, chemical synthesis, transgenic plants, bacterial recombinant DNA technology, and in specific brain regions, with potential implications for diabetes treatment and understanding.
20 papers analyzed
Insulin production begins in the pancreatic beta cells with the synthesis of preproinsulin, a precursor molecule. Preproinsulin is rapidly converted to proinsulin, which consists of three parts: the A chain, the B chain, and the connecting C-peptide . The proinsulin molecule undergoes specific proteolytic processing to form mature insulin, which includes two polypeptide chains (A and B) linked by disulfide bonds.
The conversion of proinsulin to insulin involves the action of specific proteases, namely prohormone convertases 1/3 and 2, and carboxypeptidase E. These enzymes cleave proinsulin to produce insulin and C-peptide, which are stored together in secretory granules within the beta cells.
Insulin is stored in vesicles known as insulin secretory granules (ISGs) within the beta cells. These granules undergo extensive modifications during their journey from the trans-Golgi network to the plasma membrane, where they eventually fuse and release insulin into the bloodstream . The process of granule biogenesis, maturation, and exocytosis is crucial for maintaining proper insulin levels and function.
The release of insulin from beta cells is primarily regulated by glucose levels. When blood glucose levels rise, it triggers the release of insulin from the ISGs to help lower glucose levels by promoting its uptake and storage in tissues .
Recombinant DNA technology has revolutionized insulin production, allowing for large-scale manufacturing using bacterial and yeast systems. Human insulin can be produced in Escherichia coli and Saccharomyces cerevisiae, where the insulin chains are synthesized separately and then combined to form active insulin . This method has proven to be efficient and cost-effective, meeting the growing demand for insulin due to the increasing prevalence of diabetes.
Chemical synthesis of insulin, although challenging due to its complex structure, has also seen significant advancements. Techniques have been developed to correctly fold the two chains and form the necessary disulfide bonds, enabling the production of insulin analogues with improved properties. These methods complement recombinant DNA techniques and contribute to the development of novel insulin therapies.
Recent studies have shown that insulin is also produced in the choroid plexus (ChP) of the brain. This insulin production is regulated by serotonergic signaling rather than glucose levels, indicating a unique mechanism of insulin regulation in the brain. Additionally, neurons in the cerebral cortex and hippocampus have been found to synthesize insulin, suggesting a role in local energy homeostasis and synaptic transmission.
Insulin production is a complex process involving the synthesis of precursor molecules, specific proteolytic processing, and regulated secretion from pancreatic beta cells. Advances in recombinant DNA technology and chemical synthesis have greatly enhanced our ability to produce insulin for therapeutic use. Furthermore, the discovery of insulin production in the brain opens new avenues for understanding its role in neural function and potential therapeutic applications.
Most relevant research papers on this topic